PharmaShots | Incisive News in 3 Shots

Subscribe Now

Nuvectis Pharma

Nuvectis Pharma’s NXP800 Receives the US FDA’s Orphan Drug Designation to Treat Various ARID1a-Deficient Cancers

Nuvectis Pharma’s NXP800 Receives the US FDA’s Orphan Drug Designation to Treat Various ARID1a-Deficient Cancers

August 30, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us